TOP2A and breast cancer: Drugs such as vincristine, teniposide, mitoxantrone, etoposide, epirubicin, idarubicin, daunorubicin, amsacrine, paclitaxel, dexrazoxane, doxorubicin, and fluorouracil all target TOP2A, indicating its crucial role in either the development or progression of BC.